Cerity Partners’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.9K Buy
+34,691
New +$33.1K ﹤0.01% 3405

Other funds holding OTLK

Cerity Partners's OTLK Position: Q3 2026 in Review

Cerity Partners opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 34,691 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #3405 among its holdings.

61 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.

  • Cerity Partners held 34,691 shares of Outlook Therapeutics worth $19.9K as of Q3 2026.
  • Outlook Therapeutics was a new Cerity Partners position in Q3 2026.
  • Outlook Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #3405 holding.
  • 61 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.